Variant report
Variant | nsv823045 |
---|---|
Chromosome Location | chr5:29258285-29258840 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs74828674 | chr5:29258304-29258305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113047716 | chr5:29258306-29258307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs370467144 | chr5:29258328-29258329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs78026634 | chr5:29258352-29258353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs4370285 | chr5:29258366-29258367 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs551672275 | chr5:29258378-29258379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182315174 | chr5:29258409-29258410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549766007 | chr5:29258413-29258414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186878503 | chr5:29258445-29258446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs4370286 | chr5:29258458-29258459 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs73750032 | chr5:29258475-29258476 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs552862676 | chr5:29258489-29258490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190384210 | chr5:29258506-29258507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557208936 | chr5:29258530-29258531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs4370287 | chr5:29258531-29258532 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs112016146 | chr5:29258547-29258548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs578138420 | chr5:29258556-29258557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535225696 | chr5:29258626-29258627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs4467718 | chr5:29258627-29258628 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs6148964 | chr5:29258668-29258669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs374890805 | chr5:29258715-29258716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs5023619 | chr5:29258741-29258742 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs147004343 | chr5:29258749-29258750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182578615 | chr5:29258775-29258776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12519344 | chr5:29258789-29258790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs5866922 | chr5:29258790-29258791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs11279371 | chr5:29258806-29258807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567479440 | chr5:29258834-29258835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29255000-29258600 | Weak transcription | Hela-S3 | cervix |
2 | chr5:29258600-29258800 | Enhancers | Hela-S3 | cervix |
3 | chr5:29258800-29259600 | Weak transcription | Hela-S3 | cervix |